• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Grand Rounds

What is the Impact of Folic Acid Supplementation on Postnatal Brain Development

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • In several countries, food is fortified with folic acid (synthetic, more highly bioavailable form compared to naturally occurring folate)
    • Folate levels in women of reproductive age have doubled with a concomitant reduction in neural tube defects
    • Studies show lower risk of language delay and autism in offspring exposed to prenatal folic acid (see ‘Related ObG Topics’ below)
  • Ervilmaz et al. (JAMA Psychiatry 2018) examined the associations between fetal folic acid exposure, cortical maturation and psychiatric risk in youths

METHODS:

  • Retrospective, observational clinical cohort study (1993-2001)
    • Two additional independent, observational, community-based cohorts were also used
      • One of these cohorts assessed the association of age–cortical thickness slopes with the odds of psychotic symptoms
    • Participants were between the ages of 8-18 years
    • Children were born before or during the United States-mandated grain product fortification with folic acid, which was introduced in late 1996 and fully in effect by mid-1997
    • Youths were separated into 3 age-matched groups
      • Nonexposed
      • Partially exposed
      • Fully exposed
    • All subjects received magnetic resonance imaging (MRI) to determine the association between age and cortical thickness

RESULTS:

  • 292 youths were included in the retrospective study and 1,078 from the community-based cohorts
  • The retrospective cohort (139 girls and 153 boys; mean [SD] age, 13.3 [2.3] years) demonstrated the following in the folic acid group
    • Increased Cortical thickness in bilateral frontal and temporal regions (9.9%-11.6%; corrected P < .001 to P = .03)
    • Emergence of quadratic (delayed) age-associated thinning in temporal and parietal regions (β = –11.1 to –13.9; corrected P = .002)
  • Flatter thinning profiles in frontal, temporal, and parietal regions were associated with lower odds of psychosis spectrum symptoms (odds ratio, 0.37-0.59; corrected P < .05)
  • All identified regions displayed earlier thinning in a nonexposed cohort (118 girls and 99 boys; mean [SD] age, 13.3 [2.6] years)

CONCLUSION:

  • Folic acid supplementation is associated with delayed onset of cortical thinning, which in one study was linked with lower odds of psychosis spectrum symptoms

Learn More – Primary Sources:

Association of Prenatal Exposure to Population-Wide Folic Acid Fortification With Altered Cerebral Cortex Maturation in Youths

image_pdfFavoriteLoadingFavorite

< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

NTDs and Pregnancy – Folic Acid Recommendations
Reduced Risk of Autism in Offspring Exposed to Folic Acid During Pregnancy
Practical obstetrics info for your women's healthcare practice
Cleft Lip and Palate – Considerations and Discussion Points
Do Maternal Multivitamin Supplements Decrease Risk for Autism in Offspring?

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site